Trbovlje

Cardiovascular Research

Clinical trials focusing on innovative combination therapies for heart failure patients. Research aims to evaluate new treatment approaches for individuals with specific cardiac conditions.

Heart Function Enhancement
Cardiovascular Disease Management
Therapeutic Combinations

Studies examine the effectiveness of combining empagliflozin with novel compounds to improve outcomes in patients with reduced heart function.

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Recruiting

3 1 1
Investigated Diseases:
- Cardiac failure
Investigated Drugs:
- Bi 690517
- Empagliflozin
+5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Bi 690517 Empagliflozin Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Cardiac failure

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

Trbovlje

Cardiovascular Research

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies